Latest Insider Transactions at Crispr Therapeutics Ag (CRSP)
This section provides a real-time view of insider transactions for Crispr Therapeutics Ag (CRSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CRISPR Therapeutics AG to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CRISPR Therapeutics AG's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-4.01%
|
$3,900,000
$156.55 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
10,000
-0.87%
|
$1,530,000
$153.49 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
20,375
-49.72%
|
$3,117,375
$153.49 P/Share
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
47,536
+26.88%
|
-
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
1,285,027
-81.0%
|
-
|
|
Jun 28
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
248,625
+31.17%
|
-
|
|
Jun 21
2021
|
Rodger Novak President |
SELL
Open market or private sale
|
Direct |
25,000
-0.65%
|
$3,200,000
$128.07 P/Share
|
|
Jun 15
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
30,000
-4.79%
|
$3,780,000
$126.59 P/Share
|
|
Jun 15
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+12.11%
|
$360,000
$12.57 P/Share
|
|
Jun 11
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
10,000
-7.51%
|
$1,270,000
$127.64 P/Share
|
|
Jun 01
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
779
-0.41%
|
$89,585
$115.8 P/Share
|
|
Mar 23
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
100,000
-89.52%
|
$12,700,000
$127.58 P/Share
|
|
Mar 23
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
88,000
+20.38%
|
$2,904,000
$33.17 P/Share
|
|
Mar 22
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
30,374
-9.2%
|
$4,009,368
$132.28 P/Share
|
|
Mar 10
2021
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
2,141
-5.29%
|
$265,484
$124.15 P/Share
|
|
Mar 10
2021
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+10.18%
|
-
|
|
Mar 10
2021
|
James R. Kasinger General Counsel and Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,353
-5.36%
|
$167,772
$124.15 P/Share
|
|
Mar 10
2021
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+10.08%
|
-
|
|
Mar 10
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,141
-14.09%
|
$265,484
$124.15 P/Share
|
|
Mar 10
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,583
+23.18%
|
-
|
|
Mar 10
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,526
-2.85%
|
$685,224
$124.15 P/Share
|
|
Mar 10
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,833
+5.75%
|
-
|
|
Mar 10
2021
|
Michael John Tomsicek Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,352
-41.69%
|
$167,648
$124.15 P/Share
|
|
Mar 10
2021
|
Michael John Tomsicek Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,833
+46.63%
|
-
|
|
Mar 05
2021
|
Tony W Ho Executive VP, Head of R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,585
-4.23%
|
$180,690
$114.65 P/Share
|
|
Mar 05
2021
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,333
+8.17%
|
-
|
|
Mar 01
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
798
-0.44%
|
$103,740
$130.25 P/Share
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
13,213
+9.14%
|
-
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
338,165
-53.38%
|
-
|
|
Mar 01
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
60,068
+26.47%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Direct |
47,536
+26.88%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
SELL
Other acquisition or disposition
|
Indirect |
1,285,027
-57.39%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
BUY
Other acquisition or disposition
|
Indirect |
248,625
+31.17%
|
-
|
|
Feb 19
2021
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
171,003
-12.77%
|
$25,479,447
$149.99 P/Share
|
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
27,500
-14.51%
|
$5,637,500
$205.45 P/Share
|
|
Jan 19
2021
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
27,500
+35.52%
|
$1,402,500
$51.49 P/Share
|
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Open market or private sale
|
Direct |
25,000
-6.68%
|
$5,375,000
$215.28 P/Share
|
|
Jan 15
2021
|
Lawrence Otto Klein CBO & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,010
+27.12%
|
$325,130
$13.5 P/Share
|
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-1.71%
|
$4,280,000
$214.49 P/Share
|
|
Jan 15
2021
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+8.97%
|
$20,000
$1.81 P/Share
|
|
Jan 02
2021
|
Lawrence Otto Klein CBO & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
9,392
-46.96%
|
$1,436,976
$153.11 P/Share
|
|
Dec 29
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,800
+7.01%
|
$13,800
$1.81 P/Share
|
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
SELL
Open market or private sale
|
Direct |
23,551
-5.54%
|
$3,509,099
$149.69 P/Share
|
|
Dec 21
2020
|
Tony W Ho Executive VP, Head of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
23,551
+29.05%
|
$376,816
$16.9 P/Share
|
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
7,352
-0.43%
|
$1,095,448
$149.12 P/Share
|
|
Dec 16
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Direct |
7,648
-50.79%
|
$1,139,552
$149.12 P/Share
|
|
Dec 10
2020
|
Bradley J Ph D Bolzon Director |
SELL
Open market or private sale
|
Indirect |
33,000
-1.97%
|
$4,686,000
$142.54 P/Share
|
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,000
-2.2%
|
$2,840,000
$142.92 P/Share
|
|
Dec 10
2020
|
Samarth Kulkarni Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+9.56%
|
$20,000
$1.81 P/Share
|
|
Dec 09
2020
|
James R. Kasinger General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
22,026
+49.56%
|
$286,338
$13.62 P/Share
|